Global Pulmonary Arterial Hypertension (PAH) Drugs Market to Grow at a CAGR of 3.2% During 2017-2021 - Actelion Pharmaceuticals, DAIICHI SANKYO, GlaxoSmithKline
PAH in the arteries, which carry blood from the heart to the lungs, occurs when blood vessels become narrow, making blood flow difficult. The global pulmonary arterial hypertension drugs market to grow at a CAGR of 3.2% during the period 2017-2021. The report covers the present scenario and the growth prospects of the global pulmonary arterial hypertension drugs market for 2017-2021. To calculate the market size, the report considers the MoA and the RoA.
View full press release